• Contact Us

Join us for the Policy Summit Sept. 25-26 at the Washington Marriott Georgetown in Washington, D.C.!

• Annual Meeting
  • Register
  • Sponsor & Exhibit
  • Future Annual Meetings
  • Annual Meeting Archives
    • 27th Annual Meeting Video Archive

  • Program
    • Certificate of Attendance
    • Workshops
    • Keynote Speakers

  • Abstracts
    • Present
    • Awards
    • Topics
• Membership
  • Video Library
    • Annual Meeting
    • Cancer
    • Career Skills
    • Gene Editing
    • Patients and Clinicians
    • Regulatory
    • Viral Vectors

  • Become a Member
  • Get Involved
  • Career Center
  • ASGCT Abstracts
    • Abstract Submission Windows
  • Volunteer

  • My Profile
  • Economy-Based Rates
  • Awards
  • Membership Directory
  • Scientific Committees
  • Standing Committees
• Events
  • Advancing Cell and Gene Therapies for Cancer
  • Policy Summit 2025

  • Breakthroughs in Targeted In Vivo Gene Editing
  • Professional Development Cafés

  • Molecular Therapy Presents: 25th Anniversary Special Issue
• Awards
  • Honorific Awards
    • Outstanding Achievement Award
    • Outstanding New Investigator Awards
    • George Stamatoyannopoulos Mentorship Award
    • Award for Excellence in Advancing Diversity, Equity, and Inclusion
    • Exemplary Service Award

  • Annual Meeting Awards
  • Underrepresented Populations in Gene and Cell Therapy
  • Mavis Agbandje-McKenna Scholarship and Fund

  • Career Development Awards
  • Congressional Policy Fellowship
• Outreach
  • Clinical Trials Finder
  • Community Quick Takes
    • AAV Immune Response
    • Focused Ultrasound in CGT
    • Informed Consent
    • State of the Field Highlights + Approvals for CGT in 2023
    • Access to Approved Cell and Gene Therapies
    • Genetic Testing and Clinical Trial Eligibility

  • Patient Education: Gene Therapy 101
    • Gene Therapy Basics
    • Gene Therapy Approaches
    • Clinical Trials Process
    • Vectors 101
    • Gene Editing
  • Diversity, Equity, and Inclusion
    • Biotech Discovery Labs Program

  • Patient Education: Condition Treatments
    • Beta Thalassemia & Other Blood Disorders
    • CALD and MLD
    • Spinal Muscular Atrophy
    • CAR-T Basics
    • Hemophilia
  • Global Outreach
    • 2025 Global Gene Therapy Training Course
• Publications
  • ASGCT Blog
  • The Patient Press
    • April 2025
  • The Vector
  • Quarterly Gene, Cell, and RNA Therapy Landscape Report

  • ASGCT Podcast Network
    • Giants of Gene Therapy
    • The Issue
    • The Molecular Therapy Podcast
  • The Advocate
    • Subscribe to The Advocate

  • Molecular Therapy Family
    • Molecular Therapy
    • MT Methods & Clinical Development
    • MT Nucleic Acids
    • MT Oncology
• Advocacy
  • Events and Opportunities
    • Policy Summit
    • ASGCT-FDA Liaison Meeting
    • Cell + Gene Therapy Science Series
    • Congressional Policy Fellowship
    • FDA & ASGCT: Immune Responses to AAV Vectors

  • Policy Priorities
    • Patient Access Overview
    • Regulatory Policy
    • Research Funding

  • The Advocate
    • Subscribe to The Advocate
  • Policy Statements & Letters
• About
  • Leadership
    • Board of Directors
    • Scientific Committees
    • Standing Committees
    • Staff
  • Work at ASGCT
    • Administrative Coordinator
    • Coordinator of Regulatory Programs
    • Senior Marketing Manager

  • Media
  • Our Culture
  • Strategic Plan
  • Meeting Code of Conduct
  • ASGCT Event Policies

  • Mission & Vision
    • Bylaws
  • Support ASGCT
    • Annual Meeting Support
    • Advertise in ASGCT Publications
    • Digital Programs
    • Giving
    • Year-Round Support

COVID-19 Symposium

September 15-16, 2020

Thank You for Attending the COVID-19 Symposium

We were thrilled to welcome more than 2,000 attendees to our two-day, virtual scientific symposium highlighting the advances in understanding SARS-CoV-2 and treating COVID-19. Read the daily recaps on our blog! 

 

Read More

Agenda

The ASGCT COVID-19 Symposium aims to highlight the advances in understanding SARS-CoV-2 and treating COVID-19.

Learn more

Speaker Information

Learn more about our speakers and moderators.

Learn more